[go: up one dir, main page]

TR200201103T2 - İkame edilmiş benzimidazol formülasyonları - Google Patents

İkame edilmiş benzimidazol formülasyonları

Info

Publication number
TR200201103T2
TR200201103T2 TR2002/01103T TR200201103T TR200201103T2 TR 200201103 T2 TR200201103 T2 TR 200201103T2 TR 2002/01103 T TR2002/01103 T TR 2002/01103T TR 200201103 T TR200201103 T TR 200201103T TR 200201103 T2 TR200201103 T2 TR 200201103T2
Authority
TR
Turkey
Prior art keywords
sodium
potassium salt
free
polyethylene glycol
glycol solution
Prior art date
Application number
TR2002/01103T
Other languages
English (en)
Inventor
Br�lls Mikael
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200201103T2 publication Critical patent/TR200201103T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Mevcut bulus, su içermeyen ya da neredeyse hiç su içermeyen, (I) formülüne ait bir H+,K+ -ATPase inhibitörüne ait bir sodyum ya da potasyum tuzu ya da bunun tek bir enentiomerinin sodyum ya da potasyum tuzunun bir polietilen glikol çözeltisini kapsayan dayanikli sivi formülasyonlarla ilgilidir. Alternatif olarak H+,K+ -ATPase inhibitörüne ait sodyum ya da potasyum tuzu polietilen glikol çözeltisi yerine sodyum ile potasyum hidroksitin etkin bilesik ile beraber eklenmesi ile de olusturulabilir. Bulus ayni zamanda talep edilen formülasyonun hazirlanmasiyla, dayanikli sivii formülasyonun tipta ve mide bagirsak hastaliklarinin tedavisinde kullanilmasiyla ilgildir.
TR2002/01103T 1999-10-22 2000-10-13 İkame edilmiş benzimidazol formülasyonları TR200201103T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles

Publications (1)

Publication Number Publication Date
TR200201103T2 true TR200201103T2 (tr) 2002-08-21

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01103T TR200201103T2 (tr) 1999-10-22 2000-10-13 İkame edilmiş benzimidazol formülasyonları

Country Status (35)

Country Link
US (1) US6730685B1 (tr)
EP (1) EP1274427B1 (tr)
JP (1) JP2003512327A (tr)
KR (1) KR100785603B1 (tr)
CN (1) CN1213751C (tr)
AR (1) AR029005A1 (tr)
AT (1) ATE304851T1 (tr)
AU (1) AU782866B2 (tr)
BG (1) BG65580B1 (tr)
BR (1) BR0014895A (tr)
CA (1) CA2425199C (tr)
CO (1) CO5261533A1 (tr)
CY (1) CY1106055T1 (tr)
CZ (1) CZ20021375A3 (tr)
DE (1) DE60022789T2 (tr)
DK (1) DK1274427T3 (tr)
EE (1) EE05175B1 (tr)
ES (1) ES2246903T3 (tr)
HU (1) HUP0203121A3 (tr)
IL (2) IL149107A0 (tr)
IS (1) IS2196B (tr)
MX (1) MXPA02003900A (tr)
MY (1) MY131971A (tr)
NO (1) NO329545B1 (tr)
NZ (1) NZ518155A (tr)
PL (1) PL199868B1 (tr)
RU (1) RU2286782C2 (tr)
SE (1) SE9903831D0 (tr)
SI (1) SI1274427T1 (tr)
SK (1) SK286266B6 (tr)
TR (1) TR200201103T2 (tr)
TW (1) TWI236372B (tr)
UA (1) UA74347C2 (tr)
WO (1) WO2001028558A1 (tr)
ZA (1) ZA200202905B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE342263T1 (de) * 2000-08-04 2006-11-15 Takeda Pharmaceutical Salze von benzimidazol-derivaten und deren verwendung
AU2001278755A1 (en) * 2000-08-18 2002-03-04 Takeda Chemical Industries Ltd. Injections
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US7507746B2 (en) * 2003-02-24 2009-03-24 Mitsubishi Pharma Corporation Enantiomer of tenatoprazole and the use thereof in therapy
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
EP2018151A4 (en) * 2006-05-09 2012-07-18 Astrazeneca Ab STERILIZED PARENTERAL FORMULATION WITH PROTONED PUMP INHIBITOR BY IONIZING RADIATION IN THE END TANK
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
CN107109464B (zh) 2014-11-13 2021-03-30 3M创新有限公司 用于检测样品中细菌atp的包含atp-二磷酸水解酶的试剂盒
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2025078989A1 (en) * 2023-10-11 2025-04-17 Reena Patel Stabilized pharmaceutical compositions
WO2025181379A1 (en) * 2024-03-01 2025-09-04 Etico Lifesciences Private Limited Liquid, storage stable, directly injectable, pantoprazole formulations, their uses and manufacturing

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
DK399389A (da) 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
KR930000861B1 (ko) 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
WO1994002141A1 (en) 1992-07-28 1994-02-03 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
DE69940769D1 (de) * 1998-01-20 2009-06-04 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
MY131971A (en) 2007-09-28
ATE304851T1 (de) 2005-10-15
NZ518155A (en) 2004-07-30
EP1274427B1 (en) 2005-09-21
SI1274427T1 (sl) 2006-02-28
IL149107A (en) 2008-04-13
EP1274427A1 (en) 2003-01-15
PL354926A1 (en) 2004-03-22
WO2001028558A1 (en) 2001-04-26
ES2246903T3 (es) 2006-03-01
AU1182301A (en) 2001-04-30
HK1051142A1 (en) 2003-07-25
NO20021860L (no) 2002-05-21
IL149107A0 (en) 2002-11-10
SE9903831D0 (sv) 1999-10-22
SK286266B6 (sk) 2008-06-06
US6730685B1 (en) 2004-05-04
CN1213751C (zh) 2005-08-10
NO20021860D0 (no) 2002-04-19
CN1382048A (zh) 2002-11-27
BG106602A (en) 2002-12-29
MXPA02003900A (es) 2002-09-30
BG65580B1 (bg) 2009-01-30
CO5261533A1 (es) 2003-03-31
DK1274427T3 (da) 2005-12-27
UA74347C2 (uk) 2005-12-15
PL199868B1 (pl) 2008-11-28
JP2003512327A (ja) 2003-04-02
CZ20021375A3 (cs) 2002-09-11
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
AU782866B2 (en) 2005-09-01
EE05175B1 (et) 2009-06-15
SK5392002A3 (en) 2002-10-08
HUP0203121A3 (en) 2004-01-28
HUP0203121A2 (hu) 2003-01-28
IS2196B (is) 2007-01-15
EE200200204A (et) 2003-04-15
IS6347A (is) 2002-04-17
ZA200202905B (en) 2003-07-14
KR20020059637A (ko) 2002-07-13
CA2425199C (en) 2010-12-07
AR029005A1 (es) 2003-06-04
TWI236372B (en) 2005-07-21
KR100785603B1 (ko) 2007-12-14
NO329545B1 (no) 2010-11-08
RU2286782C2 (ru) 2006-11-10
CA2425199A1 (en) 2001-04-26
CY1106055T1 (el) 2011-04-06
BR0014895A (pt) 2002-06-18

Similar Documents

Publication Publication Date Title
TR200201103T2 (tr) İkame edilmiş benzimidazol formülasyonları
ES2565991T3 (es) Composición terapéutica y uso
TR200103474T2 (tr) Bileşimlerin anti-bakteriyel madde olarak yeni kullanımları
TR199800436A2 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
TR200001399T2 (tr) Siklik amin türevleri ve ilaç olarak kullanımları.
CY1110593T1 (el) Η χρηση φαρμακευτικης συνθεσης που περιεχει παραγωγο παρα - αμινοφαινυλοξικου οξεος για τη θεραπεια των φλεγμονωδων καταστασεων του γαστρεντερικου σωληνα
TNSN03110A1 (en) Azaindoles.
PE20050822A1 (es) Derivados de florfenicol con mejor solubilidad en agua
ATE307808T1 (de) Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
ES2032595T3 (es) Una solucion de peroxido de hidrogeno estabilizada.
TR200003383T2 (tr) HIV ve diğer virüs enfeksiyonlarının tedavisine yönelik bileşimler.
ATE390414T1 (de) Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
DK1204650T3 (da) Substituerede 2-arylbenzazol-forbindelser og anvendelse deraf som antitumormidler
TR200103153T2 (tr) Yeni bileşimler
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE69224071D1 (de) Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TR199800386T1 (tr) Analjezik ajan olarak kullanilan optik aktiviteye sahip fenil pirimidin türevleri.
TR200100611T2 (tr) İbuprofen ve domperidon içeren farmasötik kompozisyonlar
BRPI0718014A2 (pt) Composto de amida ou sal do mesmo, e inibidor de formação de biopelícula, removedor de biopelícula e bactericida, cada um utilizando o composto de amida ou sal do mesmo.
ID27253A (id) Penggunaan turunan-turunan kampotesin dengan toksisitas gastrointestinal yang tereduksi
EA199900510A1 (ru) Инъекционное лекарственное средство "цитофлавин", обладающее цитопротекторным действием
TR200102306T2 (tr) Faktör Xa önleyici olarak heterosiklik türevler.
GT200000105A (es) Sal difosfato de un derivado de 4" - sustituido - 9 - desoxo - 9a - aza - 9a - homoeritromicina y sucomposicion farmaceutica.
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları